Pharma Journalist -

Insilico Medicine and Hygtia Therapeutics have entered into an exclusive global license and co-development agreement to advance ISM8969, an investigational NLRP3 inhibitor designed for…
Read More...

Wugen has received a major regulatory endorsement from the U.S. Food and Drug Administration, which has granted Breakthrough Therapy Designation to its investigational CAR-T cell…
Read More...

Charles River Laboratories International and Gazi University Faculty of Medicine have entered into a strategic collaboration aimed at advancing gene therapy research for rare genetic…
Read More...

NEOK Bio has taken a key step toward clinical development after the U.S. Food and Drug Administration approved its Investigational New Drug application for NEOK001, clearing the way for…
Read More...

Opna Bio, a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, has received a key regulatory boost for its myelofibrosis program. The U.S. Food and…
Read More...

Novo Nordisk and Aspect Biosystems have announced the expansion of their strategic partnership, entering a new phase focused on developing advanced cellular medicines for diabetes that…
Read More...

Bristol Myers Squibb (BMS) has entered into a strategic collaboration with Microsoft to accelerate the early detection of lung cancer by integrating advanced artificial intelligence…
Read More...

GSK plc and Japan-based pharmaceutical company Shionogi & Co., Ltd. have reached an agreement, alongside Pfizer Inc., to reshape the ownership structure of ViiV Healthcare, the…
Read More...

AstraZeneca has agreed to acquire AbelZeta Pharma’s remaining stake in the China development and commercialization rights to C-CAR031, consolidating full global control of the…
Read More...

iRegene Therapeutics has reached a major regulatory milestone with its lead program for Parkinson’s disease, as the U.S. Food and Drug Administration granted Regenerative Medicine…
Read More...